文献速递免疫规划传染病防控与疫情报告

BNT162b2疫苗接种后心肌炎六例报告

Myocarditis following COVID-19 mRNA vaccination.
PubMed 文献 · Vaccine · 2021-05-28

该研究报告了6例BNT162b2疫苗接种后不久发生心肌炎的病例,患者均为男性,中位年龄23岁,5例在第二剂后、1例在第一剂后出现。所有患者临床表现轻微,诊断经心脏MRI确立,且排除新冠感染。作者认为心肌炎可能为免疫接种后的不良反应,但需谨慎解读并进一步监测。

要点

  • BNT162b2疫苗接种后可能发生心肌炎,多见于年轻男性。
  • 本组6例心肌炎患者临床过程均轻微。
  • 需进一步监测以评估心肌炎与疫苗接种的关联。

核心结论

  • BNT162b2疫苗接种后发生的心肌炎可能被视为免疫接种后的不良反应,但信息应谨慎解读并需进一步监测。

研究设计与样本

  • 病例系列报告,纳入6例在急诊就诊时表现为胸痛/不适的患者,均排除既往和当前COVID-19,经心脏MRI诊断心肌炎。

主要发现

  • 5例患者在第二剂疫苗接种后出现心肌炎,1例在第一剂后出现。
  • 所有患者均为男性,中位年龄23岁。
  • 所有患者临床过程轻微,对BNT162b2疫苗有应答。

关键数值与推荐

  • 心肌炎诊断通过心脏MRI确立。
  • 实验室检测包括肌钙蛋白和C反应蛋白水平,并排除合并感染,自身免疫性疾病被认为不太可能。

临床怎么用

  • 对于BNT162b2疫苗接种后出现胸痛/不适的年轻男性,应考虑心肌炎可能并进行心脏MRI等检查。

局限性

  • 仅为6例病例系列,不能确立因果关系。
  • 作者强调信息应谨慎解读,需进一步监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. METHODS: Patients were identified upon presentation to the emergency department with symptoms of chest pain/discomfort. In all study patients, we excluded past and current COVID-19. Routine clinical and laboratory investigations for common etiologies of myocarditis were performed. Laboratory tests also included troponin and C-reactive protein levels. The diagnosis of myocarditis was established after cardiac MRI. FINDINGS: Five patients presented after the second and one after the first dose of the vaccine. All patients were males with a median age of 23 years. Myocarditis was diagnosed in all patients, there was no evidence of COVID-19 infection. Laboratory assays excluded concomitant infection; autoimmune disorder was considered unlikely. All patients responded to the BNT162b2 vaccine. The clinical course was mild in all six patients. INTERPRETATION: Our report of myocarditis after BNT162b2 vaccination may be possibly considered as an adverse reaction following immunization. We believe our information should be interpreted with caution and further surveillance is warranted.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Abu Mouch S, Roguin A, Hellou E, et al. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021. PMID: 34092429. doi:10.1016/j.vaccine.2021.05.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。